Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Information
Baicalein is a CYP2C9 and prolyl endopeptidase inhibitor.
In vitro
In vivo
Cell Data
cell lines:
Concentrations:
Incubation Time:
Powder Purity:≥97%
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Solubilité | Solubility (25°C) In vitro DMSO: 57 mg/mL (199.79 mM); Ethanol: 6 mg/mL (21.03 mM); Water: Insoluble; |
|---|---|
| Point de fusion (°C) | 256-271°C |
Notre guide de sélection des qualités couvre la pureté, le statut du stabilisant et l'adéquation à l'application pour toutes les variantes de notre catalogue.
Voir le guide des qualités Moligand™ →